Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Abbott_Laboratories
gptkb:BASF |
| gptkbp:acquisitionYear |
1975
2001 |
| gptkbp:countryOfOrigin |
gptkb:Germany
|
| gptkbp:foundedIn |
1886
|
| gptkbp:founder |
gptkb:Hans_Knoll
Albert Knoll |
| gptkbp:headquartersLocation |
gptkb:Ludwigshafen,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Knoll Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Dilaudid
Sibutramine |
| gptkbp:parentCompany |
gptkb:Abbott_Laboratories
|
| gptkbp:status |
defunct
|
| gptkbp:bfsParent |
gptkb:hydrocodone_bitartrate
gptkb:Abbott_Laboratories_(prior_to_2013_spin-off) |
| gptkbp:bfsLayer |
8
|